<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The prognosis of symptomatic intracranial <z:mp ids='MP_0006135'>artery stenosis</z:mp> (SIAS) by medical treatment is poor </plain></SENT>
<SENT sid="1" pm="."><plain>Percutaneous balloon angioplasty (<z:mp ids='MP_0002633'>PTA</z:mp>) or stenting is effective for SIAS </plain></SENT>
<SENT sid="2" pm="."><plain>However, recently, aggressive medical intervention (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e>) has progressed and some drugs have been reported to improve stenosis or prevent the progression of stenosis </plain></SENT>
<SENT sid="3" pm="."><plain>We describe a case where combination of <z:mp ids='MP_0002633'>PTA</z:mp> and the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> improved symptomatic basilar <z:mp ids='MP_0006135'>artery stenosis</z:mp> with a tortuous access route </plain></SENT>
<SENT sid="4" pm="."><plain>Case: A 78-year-old man was admitted to our hospital suffering from <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> due to severe basilar <z:mp ids='MP_0006135'>artery stenosis</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> including cilostazol, <z:chebi fb="0" ids="35664">statin</z:chebi>, and eicosapentaenoic acid failed to prevent recurrence of the <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>We performed <z:mp ids='MP_0002633'>PTA</z:mp> and 45% of the residual stenosis remained </plain></SENT>
<SENT sid="7" pm="."><plain>We continued the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> and the stenosis improved to 30% after 3 months </plain></SENT>
<SENT sid="8" pm="."><plain>Conclusion: <z:mp ids='MP_0002633'>PTA</z:mp> with minimal risk should be considered for SIAS resistant to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Even if residual stenosis remains, continuation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> may prevent recurrence of a <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>The strategy of a combination of <z:mp ids='MP_0002633'>PTA</z:mp> with minimal risk and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> may result in a better prognosis for SIAS </plain></SENT>
</text></document>